Published: Mar 24, 2026
Written by Klarity Editorial Team
Published: Mar 24, 2026

If you’re struggling with obsessive-compulsive disorder (OCD), you know how intrusive thoughts and repetitive behaviors can take over your life. The good news? Getting effective treatment has never been more accessible. In 2025, you can receive OCD medication through telehealth in all 50 states—often without ever stepping into a doctor’s office.
But navigating the rules around online prescriptions can feel confusing. Can your provider legally prescribe SSRIs via video call? Do you need an in-person visit first? What about state laws and controlled substance regulations?
This guide answers all your questions about getting OCD medication online, with up-to-date information on federal rules, state-by-state requirements, and what to expect from telehealth mental health care in 2025.
Here’s the most important thing to understand: The medications most commonly prescribed for OCD are not controlled substances. This single fact makes telehealth prescribing straightforward.
Common OCD medications include:
These selective serotonin reuptake inhibitors (SSRIs) are classified as ‘prescription legend drugs’ but are not controlled by the DEA. This means the Ryan Haight Act—the federal law requiring an in-person medical evaluation before prescribing controlled substances via telemedicine—does not apply to OCD medications.
You may have heard about DEA restrictions on telehealth prescribing, particularly the extensions of COVID-era flexibilities through December 31, 2026. These rules primarily affect controlled medications like stimulants for ADHD or benzodiazepines for anxiety. SSRIs have always been legal to prescribe via telehealth, with no special federal restrictions.
While SSRIs don’t face DEA-specific hurdles, all states require telehealth providers to meet the same standard of care as in-person treatment. This means:
Establishing a patient-provider relationship: Your clinician must conduct a thorough evaluation via live video (or occasionally phone, depending on state rules). Simply filling out an online questionnaire isn’t sufficient—you need a real-time consultation.
Proper clinical assessment: Providers must confirm you meet DSM-5 criteria for OCD, including obsessions (intrusive, recurrent thoughts) and/or compulsions (repetitive behaviors or mental rituals) that consume significant time (typically more than one hour daily) or cause marked distress.
Documentation: Every legitimate telehealth visit generates a medical record documenting your symptoms, diagnosis, treatment plan, and informed consent. This protects both you and your provider.
State licensing: Your provider must be licensed in the state where you’re physically located during the appointment. Interstate telehealth is possible, but the clinician needs appropriate credentials for your location.
As of 2025, no state requires an in-person visit before prescribing SSRIs via telehealth. Recent state legislation has focused on controlled substances, leaving non-controlled medications like SSRIs with straightforward telehealth access.
California law explicitly allows prescribing ‘dangerous drugs’ (including SSRIs) via telehealth as long as the provider conducts an ‘appropriate prior examination’ that meets the standard of care. This examination can be completed entirely via video—no in-person visit required.
Key California details:
In May 2025, New York finalized regulations requiring an initial in-person visit for telehealth prescribing of controlled substances. This aligns with anticipated federal DEA rules but explicitly does not apply to non-controlled medications like SSRIs.
Key New York details:
Texas maintains a collaborative practice model for advanced practice providers but allows straightforward SSRI prescribing via telehealth for mental health conditions.
Key Texas details:
Florida’s telehealth laws include specific carve-outs for psychiatric treatment, making OCD medication prescribing accessible online.
Key Florida details:
New Hampshire’s SB 252, effective August 2025, removed prior in-person examination requirements for telehealth prescribing, even for some controlled medications.
Key New Hampshire details:
Delaware’s 2021 Telehealth Act, updated in July 2025 with SB 101, provides clear authorization for telehealth prescribing without in-person requirements.
Key Delaware details:
Psychiatrists and primary care physicians licensed in your state can prescribe SSRIs via telehealth across all 50 states. They have unrestricted prescribing authority for non-controlled medications.
As of 2025, approximately 34 states grant nurse practitioners full practice authority, meaning they can evaluate, diagnose, and prescribe medications independently. In these states, an NP specializing in mental health can provide complete OCD treatment via telehealth without physician oversight.
States with NP full practice authority include:
Even in states requiring collaborative agreements (like Texas and Florida), NPs can prescribe SSRIs within their scope of practice under physician delegation. No state prohibits NP prescribing of SSRIs for OCD.
Physician assistants work under collaborative practice agreements nationwide but have prescribing authority for non-controlled medications like SSRIs in all states. Your telehealth provider may be a PA working under a supervising physician’s license.
When you schedule a telehealth appointment for OCD treatment, here’s what the process typically involves:
1. Identity and Location Verification
Your provider will confirm your identity and physical location to ensure they’re licensed in your state and to maintain accurate medical records.
2. Informed Consent
You’ll receive information about how telehealth works, privacy protections, what to do in an emergency, and your rights as a patient.
3. Comprehensive Psychiatric Evaluation
Your clinician will conduct a thorough assessment including:
Many providers use standardized screening tools like the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) to assess symptom severity.
4. Diagnosis and Treatment Planning
If you meet DSM-5 criteria for OCD, your provider will discuss treatment options. Evidence-based OCD treatment typically combines:
5. Prescription and Pharmacy Coordination
If medication is appropriate, your provider will send an electronic prescription to your preferred pharmacy. You’ll receive information about:
6. Follow-Up Schedule
Your first follow-up is typically scheduled 2-4 weeks after starting medication to monitor your response and any side effects. Ongoing appointments every 1-3 months help ensure your treatment remains effective.
Legitimate telehealth providers maintain the same documentation standards as in-person care. Your medical record will include:
This documentation satisfies legal requirements in all states and ensures continuity of care if you need to see another provider.
Telehealth works well for most people with OCD, particularly those who:
Some situations require in-person evaluation or more intensive treatment:
Active safety risks: If you’re experiencing suicidal ideation, recent suicide attempts, or active self-harm, in-person psychiatric care provides closer monitoring and immediate intervention when needed.
Severe or complex OCD: Very severe symptoms that significantly impair functioning may require intensive outpatient programs or residential treatment centers that combine medication, intensive ERP therapy, and 24/7 support.
Suspected bipolar disorder: SSRIs can trigger manic episodes in people with undiagnosed bipolar disorder. If your provider suspects bipolar symptoms alongside OCD, they may recommend in-person evaluation by a psychiatrist who can coordinate more complex medication management.
Co-occurring substance use: Active substance use can complicate OCD treatment and may require integrated treatment programs.
Age restrictions: Some telehealth platforms only treat adults (18+). While several SSRIs are FDA-approved for pediatric OCD, treating minors online may require specialized child psychiatry services and parental involvement.
Geographic limitations: If you’re in a very remote location without access to emergency services, in-person establishment of care may be recommended for safety.
| Medication | Typical Starting Dose | Target Dose for OCD | Important Notes |
|---|---|---|---|
| Fluoxetine (Prozac) | 20 mg daily | 40-80 mg daily | FDA-approved for OCD; long half-life means fewer withdrawal symptoms if you miss a dose |
| Sertraline (Zoloft) | 25-50 mg daily | 150-200 mg daily | FDA-approved for OCD in adults and children 6+; generally well-tolerated |
| Fluvoxamine (Luvox) | 50 mg daily | 200-300 mg daily | Specifically indicated for OCD; may cause more sedation than other SSRIs |
| Paroxetine (Paxil) | 20 mg daily | 40-60 mg daily | FDA-approved for OCD; shorter half-life means gradual tapering important |
Because SSRIs are non-controlled substances, there are no federal restrictions on prescription quantities. Common practices include:
Initial prescription: 30-day supply to assess tolerance and response
Maintenance prescriptions: 90-day supplies once stable, with refills authorized for up to 12 months
E-prescribing: Most states now require electronic prescriptions sent directly to your pharmacy
Your telehealth provider can adjust these based on your insurance coverage and clinical needs.
All SSRIs carry an FDA black box warning about increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (under 25). This doesn’t mean SSRIs cause suicide—rather, close monitoring is crucial, especially when starting treatment or adjusting doses.
What this means for telehealth patients:
Responsible telehealth providers take this warning seriously and build appropriate monitoring into your care plan.
The 2024 federal charges against executives of Done Global, a telehealth company accused of improperly prescribing controlled ADHD medications, highlighted the importance of choosing reputable providers. While this case involved stimulants (not SSRIs), it prompted increased scrutiny across the telehealth industry.
Red flags to avoid:
Green flags of quality care:
At Klarity Health, we’ve built our telehealth platform around accessible, high-quality mental health care. Our approach to OCD treatment includes:
Comprehensive evaluations: Every patient receives a thorough diagnostic assessment with a licensed psychiatric provider via video consultation. We don’t rush evaluations or prescribe without proper clinical justification.
Provider availability: We offer flexible scheduling with same-week appointments in most cases, making it easier to start treatment when you’re ready rather than waiting weeks or months for in-person appointments.
Transparent pricing: We accept both insurance and cash-pay options, with clear upfront pricing. No surprises on your bill.
Coordinated care: While we can prescribe SSRIs, we also recognize that medication alone isn’t always sufficient for OCD. We help connect patients with evidence-based therapy resources, including ERP specialists.
Ongoing support: Treatment doesn’t end with a prescription. We provide regular follow-ups, medication adjustments as needed, and responsive support between appointments.
Multi-state coverage: Our providers are licensed across numerous states, making it easy to continue care even if you relocate.
Most insurance plans now cover telehealth mental health visits at the same rate as in-person appointments. This includes:
What to verify with your insurance:
If you don’t have insurance or prefer not to use it, cash-pay telehealth is often more affordable than traditional in-person psychiatry:
Typical costs:
Platforms like Klarity Health offer competitive cash-pay pricing with no hidden fees, making quality OCD treatment accessible even without insurance coverage.
Living with OCD means dealing with thoughts and behaviors that can feel overwhelming and all-consuming. The good news is that effective treatment exists, and in 2025, it’s more accessible than ever through telehealth.
You can legally receive OCD medication via telehealth in all 50 states, with no in-person visit required in most cases. SSRIs prescribed online are just as effective as those prescribed in traditional settings, and the convenience of telehealth often means you can start treatment sooner and maintain it more consistently.
If you’re ready to explore telehealth treatment for OCD:
Ready to take control of your OCD? Klarity Health connects you with licensed psychiatric providers who specialize in OCD treatment. Book an appointment today and start your journey toward relief—from the comfort and privacy of your own home.
Federal Register – DEA/HHS Temporary Rule on Telehealth (Dec 31 2025)
Florida Healthcare Law Firm. ‘Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescribing Controlled Substances.’ Available at: https://floridahealthcarelawfirm.com/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescribing-controlled-substances-what-the-december-31-2025-rule-actually-does/
Sheppard Mullin Healthcare Law – Telehealth & In-Person Visits: Tracking Federal and State Updates
National Law Review. August 15, 2025. Available at: https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era
Center for Connected Health Policy – Online Prescribing State Laws
California Business & Professions Code §2242 and state telehealth prescribing requirements. Accessed July 2025. Available at: https://www.cchpca.org/topic/online-prescribing/
New York State Department of Health – Telehealth Prescribing Rule
Sheppard Mullin Healthcare Law Blog. ‘NY Finalizes Rule Requiring In-Person Visit for Controlled Substance Telehealth Prescribing.’ May 2025. Available at: https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Texas Board of Nursing – Advanced Practice Registered Nurse FAQ
Texas Board of Nursing. Prescription monitoring program requirements and APRN prescribing authority. Accessed 2025. Available at: https://www.bon.texas.gov/faqpracticeaprn.asp.html
Research Currency Statement: This article was verified as of January 4, 2026, using the most current federal and state telehealth regulations. DEA COVID-era telehealth flexibilities for controlled substances have been extended through December 31, 2026. SSRIs remain non-controlled substances with no federal in-person prescribing requirements. State laws were verified for California (July 2025), Texas (August 2025), New York (May 2025), Florida (August 2025), New Hampshire (August 2025), and Delaware (July 2025).
Find the right provider for your needs — select your state to find expert care near you.